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Formation of the coronary vasculature is a complex
and precisely coordinated morphogenetic process
that begins with the formation of epicardium. The
epicardium gives rise to many components of the
coronary vasculature, including fibroblasts, smooth
muscle cells, and endothelium. Hippo signaling com-
ponents have been implicated in cardiac develop-
ment and regeneration. However, a role of Hippo
signaling in the epicardium has not been explored.
Employing a combination of genetic and pharmaco-
logical approaches, we demonstrate that inhibition
of Hippo signaling mediators Yap and Taz leads to
impairedepicardial epithelial-to-mesenchymal transi-
tion (EMT) and a reduction in epicardial cell prolifera-
tion anddifferentiation into coronary endothelial cells.
We provide evidence that Yap and Taz control epicar-
dial cell behavior, in part by regulating Tbx18 and
Wt1 expression. Our findings show a role for Hippo
signaling in epicardial cell proliferation, EMT, and
cell fate specification during cardiac organogenesis.
INTRODUCTION
The coronary vasculature is required for supplying oxygenated
blood to the cardiac muscle. Proper coronary blood circulation
is essential for embryonic and adult cardiac tissue homeostasis.
Defects associated with the coronary function leads to myocar-
dial ischemia, infarction, and heart failure. Therefore, identifying
molecules and signaling pathways regulating coronary vessels
morphogenesis, remodeling, and maturation is essential in un-
derstanding the etiology of coronary diseases. The incidents of
coronary anomalies have been reported in up to 1% of the gen-
eral population (Angelini, 2002). During embryogenesis, cells
from multiple sources, including the proepicardium and epicar-1384 Cell Reports 15, 1384–1393, May 17, 2016 ª 2016 The Authors
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(Chen et al., 2014; Red-Horse et al., 2010; Wu et al., 2012).
The epicardium is a single layer of epithelial cells that covers
the heart. It develops from the proepicardial organ (PEO), a tran-
sient structure that arises from the mesothelium of the septum
transversum (Ma¨nner, 1993; Mikawa and Gourdie, 1996). The
epicardium plays a significant role in heart development and
gives rise to the majority of cells, including fibroblasts, smooth
muscle cells, and endothelium, of the coronary vasculature
(Ma¨nner, 1993; Mikawa and Gourdie, 1996; Singh and Epstein,
2012; Singh et al., 2011). Epicardium-deficient hearts exhibit
impaired cardiac function due to a thin myocardium, suggesting
that factors secreted from the epicardium are required not
only for coronary vasculature development but also for the pro-
liferation and differentiation of the underlying myocardial cells
(Ma¨nner, 1993; Ma¨nner et al., 2005; Pennisi et al., 2003). The
role of the epicardium in cardiac homeostasis was recently
explored using an epicardial injury model. Developmental gene
programs were re-activated following injury, which led to epicar-
dial cell expansion and differentiation into cardiac fibroblasts
and smooth muscle cells (Zhou et al., 2011). A better under-
standing of embryonic epicardial biology will help to understand
the pathophysiology of coronary defects and it may suggest
strategies to manipulate adult epicardial cells to facilitate
myocardial regrowth and angiogenesis after cardiac injury.
The Hippo signaling is an evolutionary conserved pathway
that control organ size by regulating cell proliferation, cell sur-
vival, and stem cell self renewal (Zhao et al., 2011). Hippo
signaling has been implicated in cardiac development as well
as in cardiac repair and regeneration after myocardial injury.
Genetic deletion, with a cardiac-specific Cre-recombinase,
of Mst1/2, Lats2, or Salvador (Salv) leads to an expansion of
ventricular myocardium due to increased cardiomyocyte prolif-
eration (Heallen et al., 2011). Global deletion of Yap results in
embryonic lethality around embryonic day 8.5 (E8.5) due to
defects in yolk sac vasculogenesis, chorioallantonic fusion,
and body axis elongation (Morin-Kensicki et al., 2006). However,
Taz knockout mice are viable through adulthood, although somecreativecommons.org/licenses/by-nc-nd/4.0/).
develop glomerulocystic kidney disease and pulmonary disease
(Xin et al., 2013). Yap and Taz double-null embryos die prior to
the morula stage, suggesting functional redundancy during early
embryonic development (Nishioka et al., 2009). Expression of a
constitutively active form of Yap in the heart results in increased
cardiomyocyte proliferation and heart size (von Gise et al., 2012;
Xin et al., 2011). Yap has been shown to regulate cardiomyocyte
proliferation by interacting with the insulin-like growth factor
(IGF) and Wnt signaling pathways (Heallen et al., 2011; Xin
et al., 2011). In addition, recent work by Zhang et al. demon-
strates that Yap can regulate epithelial-to-mesenchymal transi-
tion (EMT) of the atrioventricular cushion by modulating trans-
forming growth factor b (TGF-b)/Smad signaling (Zhang et al.,
2014). During cardiac development, Yap and Taz are functionally
redundant, but tissue-specific deletion of both molecules leads
to lethal cardiomyopathy in a gene-dose-dependent manner
(Xin et al., 2013). Despite the studies described above, a role
for Yap and Taz in the epicardium has not been explored.
Here, we show that Hippo signaling components are ex-
pressed during epicardium formation. To determine the sig-
nificance of Yap and Taz in the developing epicardium, we
generated epicardium-specific Yap/Taz double-knockout mice.
Genetic deletion of Yap and Taz using Sema3dGFPCre/+ mice
leads to embryonic lethality between E11.5 and E12.5 due to
cardiac defects. Furthermore, the inducible genetic deletion of
Yap and Taz using Wt1CreERT2/+ mice reveals impaired coronary
vasculature development. Pharmacological and genetic experi-
ments suggest that the impaired coronary vasculature develop-
ment observed in Yap/Taz mutants is due to defects in epicardial
cell proliferation, EMT, and fate determination. We provide
further evidence that Yap/Taz control epicardial cell proliferation,
EMT, and fate determination, in part by regulating Tbx18 and
Wt1 expression.
RESULTS
Hippo Signaling Components Are Expressed in the
Murine Proepicardium and Epicardium during
Development
To establish the pattern of Yap expression during epicardium
development, we performed Yap immunohistochemistry on em-
bryonic hearts from E9.5 to E12.5. At E9.5, Yap expression was
noted in the PEO, where it colocalizes with Tbx18 (Figures 1A–
1C). Yap expression is maintained in migrating proepicardial
and epicardial cells from E9.5 to E12.5 (Figures 1D–1I). To
demonstrate that Yap is expressed specifically in epicardial cells,
Yap colocalization with Wt1 was performed (Figures 1J–1L). Yap
colocalizeswithWt1 in thedevelopingepicardium.Similar toYap,
Taz expression is prominent in the epicardium from E10.5 to
E12.5 (Figures 1M–1R). In addition, we utilized heart sections
from Sema3dGFPCre/+ mice and assayed for colocalization of
Yap andGFP. At E12.5, we observedYap andGFP colocalization
in epicardial cells (Figures 1S–1U). To determine whether other
Hippo signaling components are expressed during epicardium
development, we performed qRT-PCR gene expression analysis
on RNA harvested from epicardial explants. To first establish
the robustness of the epicardial explant system, we generated
epicardial explants from Sema3dGFPCre/+;R26Tom/+ embryos todetermine the relativepercentageof fate-mappedepicardial cells
within a sample. Consistent with previous reports, the majority of
migrating cells are RFP positive, demonstrating epicardial iden-
tity (Figures 1V–1X) (Grieskamp et al., 2011; Takeichi et al.,
2013). Utilization of this explant system revealed that Yap, Taz,
and Tead1-3 are expressed by epicardial cells (Figure 1Y).
Tead4 expression was barely detectable in epicardial explant
cells. Western blot analysis demonstrated that the Hippo kinases
Lats1 and Lats2 are also expressed in epicardial cells (Figure 1Z).
Sema3dGFPCre/+-Mediated Epicardial Deletion of Yap
and Taz Leads to Embryonic Lethality
To determine a potential role for Yap and Taz in the epicardium
during coronary vasculature development, conditional Yapflox/flox
and Tazflox/flox alleles were crossed with a Sema3dGFPCre/+
knockin mouse, thereby targeting Cre-recombinase to the
PEO and epicardium (Figure S1) (Katz et al., 2012). Sema3d
is expressed by many, but not all, PEO progenitors (Katz
et al., 2012). We did not recover any Sema3dGFPCre/+:Yapflox/flox:
Tazflox/+ or Sema3dGFPCre/+:Yapflox/flox:Tazflox/flox neonates
from the breeding of Sema3dGFPCre/+:Yapflox/+:Tazflox/+ and
Yapflox/flox:Tazflox/flox mice, demonstrating that epicardial inacti-
vation of Yap and Taz is embryonic lethal (Figure 2A). Yap plays
a dominant role compared to Taz in Sema3d-expressing cells as
loss of both alleles of Yap in a Taz heterozygous background
leads to postnatal lethality, while loss of Taz in a Yap heterozy-
gous background produced viable mice (Figure 2A). Genotyping
of embryos from timed matings showed that the loss of Yap and
Taz resulted in embryonic lethality between E11.5 and E12.5
(Figure 2A). At E11.5, double-null embryos were smaller than
control littermates and occasionally showed hemorrhage,
consistent with embryonic lethality due to cardiovascular insuffi-
ciency (Figures 2B and 2C), although loss of Yap/Taz due to
Sema3d-Cre expression in other tissues could also be respon-
sible or contributory. To better understand the cardiac defects
caused by epicardial deletion of Yap and Taz, we performed a
detailed histological examination of both mutant and control
embryos at E10.5 and E11.5 (Figures 2D–2L). At E11.5, immuno-
staining for the cardiac marker MF-20 showed thin and frag-
mented myocardium in mutant hearts, but not in controls, sug-
gesting that Yap and Taz may play a role in modulating
paracrine effects of epicardial cells on adjacent myocardiaum
(Figures 2D and 2E). However, the myocardium of mutant
embryos at E10.5 did not display any obvious morphological
defects (Figures 2F, and 2G). Fate-mapping analysis using
Sema3dGFPCre/+ mice showed that epicardial formation was
grossly intact in mutants compared to controls, suggesting
that Yap and Taz are not required for the initial migration of
Sema3dGFPCre/+ proepicardial cells over the heart (Figures 2H
and 2I). However, Ki67 staining showed a significant reduction
in epicardial cell proliferation in mutant hearts compared to con-
trols (Figures 2J–2L). To determinewhether the reducedmyocar-
dial thickness in mutants could be due to impaired epicardial-
myocardial signaling, we measured expression of paracrine
factors known to regulate myocardial growth and observed
significantly lower expression of Fgf9, Raldh2, and Wnt5a in
mutant explants. There was no significant difference in the
expression of Fgf16, Fgf20, EPO, Igf2, and Wnt9b (Figure 2M).Cell Reports 15, 1384–1393, May 17, 2016 1385
Figure 1. Hippo Signaling Mediators Are Expressed in Proepicardial and Migrating Epicardial Cells during Embryonic Development
(A–C) Immunohistochemistry for Yap and Tbx18was performed on E9.5mouse heart sections. (A)Magnified view of the PEO shows Yap expression in the PEO (red
arrows). (BandC)Merged imageshows thatYapandTbx18 (green arrows) are co-localizedwithinPEO (yellowarrows).Nucleiwere visualizedbyDAPI staining (blue).
(D–O) Immunohistochemistry for Yap was performed on E10.5–E12.5 mouse heart sections. (D–I) Yap is expressed in the developing epicardium of E10.5–E12.5
hearts. (J–L) Yap and Wt1 expression are co-localized in the epicardium.
(M–R) Immunohistochemistry for Taz was performed on E10.5 to E12.5 mouse heart sections.
(S–U) Immunohistochemistry with an anti-GFP antibody on Sema3dGFPCre/+ embryos. Yap and GFP expression are co-localized in the epicardium.
(V–X) Epicardial explants from Sema3dGFPCre/+;R26Tom/+ embryos. The majority of the epicardial cells in the explant are RFP positive.
(Y) Real-time qPCR for the Hippo signaling mediators Yap, Taz, Tead1, Tead2, Tead3, and Tead4 using RNA isolated from epicardial explants. Tbx18 andWt1 are
presented as controls.
(Z) Western blot analysis for Lats1 and Lats2 was performed using total lysates from wild-type E12.5 hearts and epicardial explants. Gapdh is shown as a loading
control.
RA, right atrium; LA, left atrium; LV, left ventricle; RV, right ventricle; PE, proepicardium; Epi, epicardium; Myo, myocardium. Scale bars, 100 mm.Genetic Deletion and Pharmacological Inhibition of Yap
and Taz Leads to Impaired Epicardial EMT and
Differentiation into Coronary Endothelial Cells
To allow for the assessment of older Yapflox/flox:Tazflox/flox epicar-
dial-deleted embryos, we deleted Yap and Taz in the epicardium1386 Cell Reports 15, 1384–1393, May 17, 2016using an inducible Wt1CreERT2/+ mouse (Zhou et al., 2008).
Cre-recombinase activity was induced at E11.5, and we did not
recover any Wt1CreERT2/+:Yapflox/flox:Tazflox/flox postnatal pups,
indicating embryonic lethality (Figure S2A). To determine if loss
of Yap and Taz in the epicardium has effects on coronary
Figure 2. Sema3dGFPCre/+-Mediated Dele-
tion of Yap and Taz Leads to Embryonic
Lethality
(A) Genotyping result of embryos and pups from
Sema3dGFPCre/+:Yapflox/+:Tazflox/+ and Yapflox/flox:
Tazflox/flox cross.
(B and C) Compared with control (B), Yap/Taz
mutant embryos show reduced body size and
hemorrhage (C).
(D–G) MF-20 immunohistochemistry of trans-
verse sections from E10.5 and E11.5 control and
Sema3dGFPCre/+:Yapflox/flox:Tazflox/flox embryos.
(H–I) Whole mount fluorescence view of E10.5
Sema3dGFPCre/+:Yapflox/+:Tazflox/+:R26mTmG/+ and
Sema3dGFPCre/+:Yapflox/flox:Tazflox/flox:R26mTmG/+
hearts.
(J–L) Immunostaining for Ki67, MF-20 and
DAPI were performed on heart sections from
E10.5 control (J) and Sema3dGFPCre/+:Yapflox/flox:
Tazflox/flox (K) embryos. Quantification of Ki67-
positive cells was performed on four to six
sections each from four individual hearts and
averaged (L).
(M) Real-time qPCR for Fgf9, Fgf16, Fgf20, EPO,
Igf2, Raldh2, Wnt5a, and Wnt9b on RNA iso-
lated from control and Sema3dGFPCre/+:Yapflox/flox:
Tazflox/flox explants. Significant differences were
defined by *p < 0.05. Scale bars, 100 mm.vasculature development, whole-mount PECAM1 immuno-
staining was performed on control and Wt1CreERT2/+:Yapflox/flox:
Tazflox/flox mutant E15.5 hearts. PECAM1 staining of mutantCell Rhearts revealed severely disrupted coro-
nary development compared to littermate
controls.Control hearts showedanexten-
sive network of mature coronary vessels
largely on the posterior side of the heart,
whereas mutant hearts showed fewer
primitive vessels, suggesting that Yap
and Taz are required for patterning and/
or remodeling of the coronary vasculature
(Figure 3A). As with the Sema3dGFPCre/+:
Yapflox/flox:Tazflox/flox cross, epicardial cell
proliferation was significantly reduced in
Wt1CreERT2/+:Yapflox/flox:Tazflox/flox hearts
(Figure 3B). To determine whether epicar-
dial cell migration into the underlying
myocardium is affected, we generated
Wt1CreERT2/+:Yapflox/+:Tazflox/+;R26LacZ/+
and Wt1CreERT2/+:Yapflox/flox:Tazflox/flox;
R26LacZ/+ embryos. To trace epicardial-
derived cells lacking Yap and Taz, we
induced Cre-mediated recombination
just prior to EMT (E11.5) and analyzed
migration atE15.5.Usingb-galactosidase
activity to follow the epicardial-derived
cells, we observed a significant reduction
in the number of b-gal+ cells in Yap/Taz
mutants compared to littermate controls
hearts (Figure 3C).Additionally, we performed an ex vivo collagen gel invasion
assay using epicardial explants from control and Wt1CreERT2/+:
Yapflox/flox:Tazflox/floxE12.5 embryos. Tamoxifenwas administeredeports 15, 1384–1393, May 17, 2016 1387
for 72 hr to induce Cre-recombinase activity. Epicardium-derived
cells were visualized by phalloidin staining. In contrast to control,
fewer epicardial cells migrated into the collagen gel from
Wt1CreERT2/+:Yapflox/flox:Tazflox/flox explants (Figure S2B). To deter-
mine whether Hippo signaling components are required for
coronary endothelial cell formation, we performed b-galactosi-
dase/PECAM1doublestainingoncryosections fromWt1CreERT2/+:
Yapflox/+:Tazflox/+;R26LacZ/+ andWt1CreERT2/+:Yapflox/flox:Tazflox/flox;
R26LacZ/+ hearts and quantified the number of epicardial-derived
endothelial cells (PECAM1+; b-gal+) as a percentage of the total
number of b-gal+ cells in the myocardium. Deletion of Yap and
Taz resulted in a significant reduction of epicardial-derived endo-
thelial cells, suggesting a defect or delay in fate determination
(Figure 3D). Epicardial contribution to smooth muscle cells and
fibroblasts was also significantly reduced (Figures 3E and 3F).
To better understand the underlying molecular changes, we
measured the expression of regulatory genes involved in epicar-
dial development and EMT and detected significant downregula-
tion of Tbx18,Wt1, Twist1, Snail1, Slug, Zeb1, and N-cadherin in
mutants compared to controls. E-cadherin levels were elevated
in mutants compared to controls. There was no significant differ-
ence in the expression of a4-integrin, b-catenin, or Cnn1 (Figures
3G and 3H).
To further validate our results regarding defective epicardial
cell migration in the Wt1CreERT2/+:Yapflox/flox:Tazflox/flox animals,
a collagen gel invasion assaywas performed using epicardial ex-
plants fromwild-type E12.5 embryos in the presence or absence
of the chemical inhibitor verteporfin or protoporphyrin, drugs
known to disrupt the physical interaction between Yap and
Tead factors (Liu-Chittenden et al., 2012). In control explants
(treated with vehicle alone, i.e., DMSO), epicardial cells migrated
away from the explant. Fewer migrating epicardial cells were
evident in explants treated with either of the Hippo inhibitors
(Figures S3A and S3B). Interestingly, verteporfin displayed
stronger inhibitory effects in our explant assays compared to
protoporphyrin IX; therefore, we used verteporfin in subse-
quent experiments. The impaired migration of the verteporfin
or protoporphyrin-IX-treated epicardial cells was associated
with decreased expression of genes regulating epicardial EMT
(Figures S3C and S3D).
Hippo Signaling Components Regulate Tbx18 andWt1
Promoters
We next assessed whether Yap and Taz can regulate epicardial
cell proliferation, EMT, and fate specification, at least in part, by
modulating Tbx18 andWt1 promoter activity. Analysis of the 2 kb
of genomic sequence upstream of the transcriptional start sites
of Tbx18 and Wt1 revealed two consensus Tead binding se-
quences (TBSs) in each promoter (Figures 4A and 4B). Pro-
moters were PCR-amplified, cloned into a luciferase reporter
plasmid, and tested in luciferase reporter assays. Yap expres-
sion strongly activates both Tbx18 andWt1 promoter-luciferase
activity. In contrast, Taz activates the Tbx18 promoter but fails to
activate theWt1 promoter (Figure 4C). Mutation of the TBS sites
within the Tbx18 and Wt1 promoters significantly reduced the
ability of Yap to activate these constructs (Figure 4D). Chromatin
immunoprecipitation (ChIP) assays demonstrated direct binding
of Yap/Taz to the Tbx18 and Wt1 promoters (Figure 4E).1388 Cell Reports 15, 1384–1393, May 17, 2016Further evidence to indicate that Tead binding is necessary for
Yap activation of these promoters derives from experiments in
which verteporfin (5 mM)was added 24 hr after transfection. Acti-
vation of Tbx18 andWt1 promoters by Yapwas completely abol-
ished by verteporfin (Figure 4F). We further examined whether
the upstream Hippo kinases Mst1 and Lats2 could modulate re-
porter activity in response to Yap. Co-expression of Yap with
Mst1 or Lats2, but not the kinase-inactive mutants (Mst1-K59R
or LATS2-D809A), abrogated Yap-induced activation of the
Tbx18 and Wt1 luciferase reporters (Figures 4G and 4H). Mst2
and its kinase-inactive mutant (Mst2-K56R) failed to modulate
either the Tbx18 or the Wt1 promoter (Figure S4). These results
suggest that Yap regulates coronary vascular formation in part
by directly regulating Tbx18 and Wt1 expression in association
with Tead factors.
DISCUSSION
Recent studies have implicated Hippo signaling in cardiac devel-
opment and regeneration. However, a role for Hippo signaling in
coronary vasculature formation has not been explored. In the
present study, we have demonstrated that Hippo signaling com-
ponents are not only strongly expressed in the epicardium but
also required for coronary vasculature development and remod-
eling and for expression of some epicardial-derived growth
factors, including Fgf9, Raldh2, and Wnt5a. Hippo signaling me-
diators Yap and Taz regulate epicardial EMT and epicardial cell
proliferation and differentiation into coronary endothelial cells.
We provide evidence that Yap and Taz control epicardial cell
behavior, in part by regulating Tbx18 and Wt1 expression. Both
Tbx18 and Wt1 promoters are more strongly activated by Yap
than by Taz, and our genetic data support a dominant role for
Yap compared to Taz during coronary vasculature formation.
Proepicardial cells migrate and adhere to the embryonic
myocardial surface and spread over the myocardium enveloping
the entire heart. The molecular mechanisms that regulate
adhesion andmigration of the proepicardial cells as they migrate
over the myocardium appear to be intact in Sema3dGFPCre/+:
Yapflox/flox:Tazflox/flox hearts. The formation of epicardium is simi-
larly initially normal in other mousemodels engineered with other
mutated epicardial genes (Greulich et al., 2012; von Gise et al.,
2011; Wu et al., 2013). The formation of the epicardium requires
extensive proliferation and migration of proepicardial cells.
Consistent with the role of Yap and Taz as regulators of prolifer-
ation in other systems, a significant decrease in the proliferation
rate of Sema3dGFPCre/+:Yapflox/flox:Tazflox/flox epicardial cells was
observed when compared to controls. Proliferation of epicardial
cells is required for EMT as epicardial cells undergoing cell-cycle
arrest fail to invade the myocardium (Wu et al., 2010). Reduced
proliferation of epicardial cells seen in Wt1CreERT2/+:Yapflox/flox:
Tazflox/flox mice may therefore contribute to deficient EMT and
subsequent migration of epicardial derivatives into underlying
myocardium. Paracrine signals from the epicardium are required
for myocardial expansion. The observed decrease in Fgf9,
Raldh2, andWnt5a expression suggests that signaling between
the epicardium and myocardium is affected in Sema3dGFPCre/+:
Yapflox/flox:Tazflox/flox embryos, which likely contributes to the
myocardial defects.
Figure 3. Genetic Targeting of Hippo Signaling Leads to Coronary Vasculature Defects due to Impaired Epicardial Cell Proliferation,
EMT, and Fate Determination
Epicardial-specific deletion of Hippo signaling components Yap and Taz was achieved using an inducible Cre line (Wt1CreERT2/+). Cre activity was induced at
E11.5 and hearts were harvested at E15.5.
(A) Whole-mount PECAM1 staining was performed on E15.5 hearts from control andWt1CreERT2/+:Yapflox/flox:Tazflox/flox embryos to analyze coronary vasculature
development. Arrows highlight the area where differences are most obvious.
(B) Immunostaining for Ki67 and MF-20 were performed on heart sections from control and Wt1CreERT2/+:Yapflox/flox:Tazflox/flox embryos. Quantification was
performed on six to eight sections each from three individual hearts and averaged.
(C) Cryosections fromWt1CreERT2/+:Yapflox/+:Tazflox/+;R26LacZ/+ andWt1CreERT2/+:Yapflox/flox:Tazflox/flox;R26LacZ/+ were stained for b-galactosidase (b-gal) activity,
and the number of b-gal+ cells in the myocardium of mutant hearts was quantified and expressed as a percent of the number of cells quantified in controls.
(legend continued on next page)
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Hippo signaling has been recently implicated in cell fate
determination in multiple organs (Imajo et al., 2015; Yimlamai
et al., 2014). However, the role of Hippo signaling components
in epicardial cell fate determination has not been explored.
Recently, we demonstrated that Sema3d/Scx-positive proe-
picardial cells are competent to differentiate into coronary
endothelial cells in vivo and in vitro (Katz et al., 2012). We
were unable to definitively determine if cell fate determination
is affected in Sema3dGFPCre/+:Yapflox/flox:Tazflox/flox embryos
due to early embryonic lethality. We observed decreased
endothelial, smooth muscle, and fibroblast cells as a per-
centage of total epicardial derivatives in mutant hearts, but
embryonic lethality precluded us from determining if these de-
ficiencies resulted from delayed differentiation or a failure of
fate specification.
Yap and Taz may regulate epicardial cell proliferation, EMT,
and fate determination via multiple mechanisms. In this study,
we provide evidence that Yap/Taz function in part by directly
modulating Tbx18 and Wt1 expression. Members of the T-box
family of transcription factors regulate a variety of developmental
processes, including coronary vasculature development. Tbx18-
deficient hearts show abnormal coronary vascular plexus forma-
tion due to impaired epicardial signaling, cell proliferation, and
cell fate determination (Greulich et al., 2012; Wu et al., 2013).
Tbx5, a gene mutated in Holt-Oram syndrome, is expressed in
the PEO and epicardium. Tbx5 mutant hearts show abnormal
coronary vasculature due to impaired production of epicardial-
derived cells and their migration into the underlying myocardium
(Diman et al., 2014; Hatcher et al., 2004). Interestingly, Yap
and Taz interact with Tbx5 and regulate Tbx5-dependent gene
programs (Murakami et al., 2005). Wt1 regulates epicardial
EMT and myocardial growth by controlling Snail and E-cadherin
expression (Martı´nez-Estrada et al., 2010), promoting Wnt/
b-catenin signaling and expression ofWnt5a andRaldh2 (Guadix
et al., 2011; von Gise et al., 2011). Yap can also regulate endo-
cardial cell proliferation and EMT through modulation of TGF-
b/Smad signaling (Zhang et al., 2014).Wt1 is expressed by tumor
vessels, regulates PECAM1 expression and conditional deletion
of Wt1 in endothelial cells results regression of tumor vasculari-
zation (Wagner et al., 2014). Recent studies have implicatedWt1
in cell fate determination in other tissues (Wen et al., 2014; Zhang
et al., 2015). Since Yap and Wt1 are co-expressed in many tis-
sues during development and disease, our findings may have
broad relevance (Hiemer et al., 2014; Loeb et al., 2001).
In summary, we have provided evidence for the role of Hippo
signaling in epicardial biology and coronary vascular develop-
ment. Future work will focus on the role of Hippo signaling in
the adult epicardium and its role in myocardial regeneration after
injury.(D) Immunohistochemistry of X-galactosidase (X-gal)-stained cryosections with P
percent of total X-gal stained cells.
(E) Immunohistochemistry of X-gal-stained cryosections with SM22a to visualize
(F) Immunohistochemistry of X-gal-stained cryosections with DDR2 to visualize e
(G) Real-time qPCR for Yap, Taz, N-cadherin,Wt1, Tbx18, Twist1, a4-integrin, Sn
and Wt1CreERT2/+:Yapflox/flox:Tazflox/flox explants treated with 4-hydroxytamoxifen.
(H) Immunostaining for E-cadherin and N-cadherin on heart sections from contro
defined by *p < 0.05. Scale bars, 100 mm.
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Generation of Yap/Taz Mutant Mice
Epicardium-specific Yap/Taz mutant mice were generated by crossing
the Sema3dGFPCre/+ or Wt1CreERT2/+ transgenic line with Yapflox/flox,Tazflox/flox
mice (Katz et al., 2012; Xin et al., 2011, 2013; Zhou et al., 2008). Resulting
Sema3dGFPCre/+;Yapflox/+,Tazflox/+ or Wt1CreERT2/+;Yapflox/+,Tazflox/+ offspring
were then backcrossed to Yapflox/flox,Tazflox/flox mice to obtain either
Wt1CreERT2/+;Yapflox/flox,Tazflox/flox or Sema3dGFPCre/+;Yapflox/flox,Tazflox/flox mice.
Cre activity in Wt1CreERT2/+ mice was induced at E11.5 by oral administration
of 3.5 mg tamoxifen (Sigma, T5648). Tamoxifen was dissolved in ethanol and
then emulsifiedwith corn oil to a final concentration of 12.5mg/ml before admin-
istration. Yap and Taz floxed animals were genotyped as described previously
(Xin et al., 2011, 2013). The Yapflox/flox and Tazflox/flox alleles were generated in
the laboratory of ProfessorEricN.Olsonat theUniversity of Texas Southwestern
Medical Center (Dallas, TX). All mice were maintained on a mixed genetic
background. All animal protocols were approved either by the University of
Pennsylvania institutional animal care and use committee or the SingHealth
institutional animal care and use committee.
Histology and Immunohistochemistry
Histology and immunohistochemistry were performed as described previously
(Singhet al., 2011).Briefly, embryosweredissected inPBSandfixed in4%para-
formaldehyde overnight at 4C. Embryos were washedwith PBS, dehydrated in
an ethanol series, and stored in 100% ethanol at20C. Immunohistochemical
detection was performed on paraffin sections of paraformaldehyde (PFA)-fixed
hearts. Primary antibodies used for immunohistochemistry were anti-Yap rabbit
polyclonal (Cell Signaling Technology, catalog no. 4912S), anti-Taz (V386) rabbit
polyclonal (Cell SignalingTechnology, catalogno. 4883), anti-GFPantibodygoat
polyclonal (Abcam, catalog no. ab6673), anti-Tbx18 goat polyclonal (Santa Cruz
Biotechnology, catalog no. sc-17869), and anti-Wt1 rabbit polyclonal (Santa
Cruz Biotechnology, catalog no. sc-192). Whole-mount immunostaining for
PECAM1 was carried out as described previously (Singh et al., 2011). Briefly,
endogenous peroxidase activity was blocked with 5% H2O2/methanol for
60 min at room temperature. The rat anti-mouse PECAM1 primary antibody
(BD PharMingen, catalog no. 553370) was applied overnight at 4C at a dilution
of 1:200. The secondary antibody goat anti-rat IgG-HRP (Abcam, catalog no.
ab6120) was applied overnight at 4C at a dilution of 1:500 color development
was performed using a DAB kit (Vector Laboratories, SK-4100).
Plasmids
Mouse Tbx18 and Wt1 promoters (2 kb) were amplified and cloned into
pGL4.27 vector (Promega) for use in luciferase assays. For mutation of TBSs
in Tbx18 and Wt1 promoters, an 300-bp DNA fragment (150 bp on each
side of the TBS) was amplified and cloned into pGL4.27 vector and used as
control. Mini genes for same fragment differing only by the presence of a
mutated TBS were purchased from Integrated DNA Technologies (IDT) and
subsequently cloned into pGL4.27 vector. In Tbx18 promoter, mutant TBS-1
and TBS-2 represent the sequence 50-CGATAC-30 and 50-TCATAC-30, respec-
tively. In Wt1 promoter, mutant TBS-1 and TBS-2 represent the sequence
50-TCATAC-30. Mouse Yap and Taz expression vectors were previously
described (Murakami et al., 2005) and provided by Professor Eric Olson’s
lab. Murine hippo kinases Mst1 and Mst1-KI were previously described (Lin
et al., 2002) and obtained from Addgene (Addgene plasmids 1965 and
1966). Expression plasmids for human hippo kinases LATS2 and LATS2-KI
were provided by Dr. D. Pan (Dong et al., 2007).ECAM1 to identify epicardial-derived endothelial cells and quantification as a
epicardial-derived smooth muscle cells and quantification.
picardial-derived fibroblast cells and quantification.
ail1, Cnn1, E-cadherin, b-catenin, Slug, and Zeb1 on RNA isolated from control
l and Wt1CreERT2/+:Yapflox/flox:Tazflox/flox embryos. Significant differences were
(legend on next page)
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Luciferase Assay
For luciferase reporter assay, HEK293T cells were seeded in 12-well plates the
day before transfection. The Tbx18 or Wt1 luciferase reporter plasmid along
with other indicated plasmids was co-transfected into HEK293T cells using
FuGENE6 reagent (Promega, catalog no. E2691). For transfection control
50 ng of lacZ expression plasmid was utilized in all the wells. All transfections
maintained an equal concentration of total DNA with the inclusion of the
pcDNA3.1 empty vector (Invitrogen). Cells were subjected to lysis 60 hr
posttransfection using reporter lysis buffer (Promega, catalog No. E3971).
Luciferase activities were assayed in the cell lysates (20 ml) using the Luciferase
Reporter Assay System kit (Promega, catalog no. E1500). Lysates were also
assayed for b-galactosidase activity using the b-Galactosidase Enzyme Assay
System (Promega, Cat. no. E2000). The measured luciferase reporter activity
was normalized to b-galactosidase activity. The luciferase assay results
were reproduced in at least three independent experiments. All experiments
were performed in duplicate, and the representative data are shown in the
figures. During all the experiments, HEK293T cells were maintained in
DMEM supplemented with 10% fetal bovine serum, penicillin, and strepto-
mycin. In case of verteporfin treatment, inhibitor was added into the medium
24 hr posttransfection.
Statistical Analysis
Statistical analyses were performed using the two-tailed Student’s t test. Data
are expressed as mean ± SD. Differences were considered significant when
the p value was < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
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